Navigation Links
MedClean Technologies Announces Third Quarter Results

BETHLEHEM, Pa., Nov. 14, 2011 /PRNewswire/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the 2011 third quarter for the period ended September 30, 2011.

Some recent highlights include:

The company has dramatically improved its operating structure over the last two years, with improvements to the following key metrics, representing tangible progress:

  • Focus on recurring revenue opportunities will start to add to consistent minimum revenue reported on a quarterly basis:
    • MedClean is averaging $62,000 per quarter in contract maintenance. Any new systems sales going forward will increase this figure incrementally, typically adding $7,500k per quarter per sale.
    • For corrective maintenance, MedClean has averaged $74,000 per quarter over the past eight quarters. This number will fluctuate quarterly, but management expects the amount to remain close to its running average per quarter going forward.
    • MedClean's new ecommerce line of business (MedClean GPO), which was launched in the third quarter, generated $24,000 for the third quarter. Management expects this to ramp to a quarterly run rate of approximately $60,000 starting in Q1 2012. Additional upside is attainable as the current annual market for disposal sharps alone is $280 million and the Company will also be selling other mainstream consumable products such as red bags, autoclave bags, boxes, etc., that comprise an even greater annual market spend.
    • Consumables for MedClean Systems (cart liners, deodorizer, supplies, etc.,) are at a run rate of $34,500K per quarter and incremental system sales add approximately $3,000 to $5,000 per quarter.
    • In aggregate, MedClean is now at a quarterly revenue run rate of $194,500K and starting in Q1 2012, management expects to average approximately $250,000 per quarter for annual revenue (including the expected increase in ecommerce products and revenue associated with new sales plus revenue generated from the sale of consumables to our processing center/distributor partners). This equates to recurring revenue totaling $1.0 million, which is $103,000 greater than our total revenue reported for all of 2010.
    • The profit margin for MedClean's recurring revenue streams is generally around 50%.
    • The current expected cash burn run rate is approximately $1.6 million annually. The cash burn run rate has decreased by 34% percent, or $77,000, per month compared to 2009 when the new management team took over and is currently 12% lower than one year ago. Major contributing factors include a 75% reduction in corporate headquarter expense, a reduction in lease payments from $21,000 per month in 2009 to $5,500 currently; a 44% decrease in wages and salaries through the first nine months of 2011 to $1.67 million compared to $2.3 million for the same period one year ago; and a reduction in third-party consulting services of $24,000 per month.  (The Company recently completed its relocation from Bethel, CT to Bethlehem, PA).
    • With the expected revenue of $1.0 million in consumable and maintenance revenue for 2012 at 50% margin, management expects gross profit from this division to be $500,000.  At the current cash burn rate of $1.6 million annually that leaves $1.1 million in annual cash burn before MedClean System sales and installations.
    • Through the first nine months of 2011, MedClean has sold and installed three systems.  By continuing on the same pace in 2012 the Company could achieve positive cash flow by selling and installing (or installing potions of backlog) four systems at an average price of $750,000, using current system sales margin of 35%
    • MedClean currently has nine deals in advanced stages in its pipeline that have been quoted and proposed at or above our target pricing level.  Management is currently negotiating specific project details on several installations for items in its backlog.  Of the nine deals, seven have been generated by MedClean's distribution partners.

"The run rate for our current business, not including the incremental maintenance and consumable revenue from any additional system sales or further increases from our newly launched MedClean GPO business line, demonstrates that we have made significant strides in creating a self-sustaining, cash generating business model," stated David Laky, President & CEO of MedClean Technologies, Inc. "The transformation of our business has taken longer than we initially expected, due in large part to the state of the business we inherited, but our efforts have culminated in the creation of a sustainable business model.  The expansion of our service offerings into an integrated waste stream service provider adds more opportunity for recurring service revenues and will continue to reduce our dependency on one time sales. As we further prove out our operating results and show the leverage we have developed within our operational model, we believe the market will respond in a positive manner."

In addition to the operational update the Company has indicated above based on tangible results, there are also several other opportunities Management has positioned the company to take advantage of:

  • Develop "localized" waste processing center facilities at stand-alone locations, utilizing contracts with multiple nearby medical waste producers
    • MedClean is currently working with several partners to move forward on this venture and expect to finance the facilities in a joint venture structure utilizing a debt structure that will be based at the plant level.
    • Management's initial goal has been to establish the operational model and infrastructure required to enable the Company to expand into a service and recurring revenue model. Expansion into the "localized" waste processing center model will leverage the Company's new operational model and current infrastructure and will not impact  or extend the time it will take to achieve cash flow positive status.
    • Management has identified two partners at two separate locations where permitting and long-term waste contracts with surrounding medical facilities have conditionally been approved and would be utilized pending financial approval.
    • The Company expects to generate approximately $500,000 per year in revenue per facility based upon preliminary contract discussions with the surrounding waste generators and partners.
    • There are five to six additional locations that have been identified as potential follow-on locations with the model being repeatable in virtually any metropolitan area across the U.S. (the model requires only several millions of pounds of waste to be profitable).

Mr. Laky added, "Based on the business overview we have provided here today, and the progress we expect to achieve in the next few months, we anticipate conducting a conference call in conjunction with our fourth quarter and year-end financial disclosure. This call, which is expected to include a question and answer session for shareholders, is expected to be sometime in late March, pending timing of our year-end audit. We feel this will provide the best forum to provide additional color on our progress as over the past six months we have been predominantly focused on operations of the company."

Third Quarter Financial Results:

Total revenue for the quarter ended September 30, 2011 was $602,947 compared with $306,825 for the same period in 2010, an increase of  $296,121 million, or 96.5%.  In 2011 the Company was able to deliver systems completing contractual obligations and meeting revenue recognition policies totaling $445,200 versus $0 for the period in 2010.  Revenues derived from the sale of consumables, component parts, service billings, and amortization of maintenance contracts decreased by $149,079 or 48.6% in the current quarter to $157,146.  The decrease in service billings was a result of fewer service calls required due to equipment issues. Service billings will continue to fluctuate period to period based upon equipment service requirements.

Gross profit on system revenue during the three months ended September 30, 2011, was $156,443 compared to $0 for the same period in 2010. Gross profit on the sale of consumables, component parts, service billings and amortization of maintenance contracts during the three months ended September 30, 2011, was $91,608 compared to $253,741 for the same period in 2010.

Net loss for the three month period ended September 30, 2011, was $648,746, compared to a loss of $750,158 for the same period in 2010.

Year-To-Date Financial Results:

Total revenue for the nine months ended September 30, 2011, was $1,387,127, compared with $707,450 for the same period in 2010, an increase of $679,677 or 96.1%. System revenue during the nine month ended September 30, 2011, was $895,200, compared to $0 in 2010. The increase in system revenue was the result of the completion of the Company's first containerized system and the installation of a fixed based system. Revenues derived from the sale of consumables, component parts, service billings and amortization of maintenance contracts decreased by $215,523 or 30.5% in the current period to $491,927. The decrease in service billings was a result of fewer service calls required due to equipment failure. Service billings will continue to fluctuate from period to period based upon equipment failure, whether through operator error or wear and tear, and pre-scheduled service activities such as equipment relocation. Service revenue attributable to contract revenues is recognized at the time of performance and not at the time of contract execution.

The Company has filed its Form 10-Q for the period ended September 30, 2011 with the Securities and Exchange Commission, and investors are encouraged to visit to review this document, which includes financial tables and additional detail for the quarter ended September 30, 2011.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethlehem, Pennsylvania. Further information on MedClean can be found at and in filings with the Securities and Exchange Commission found at

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Cameron Donahue
Hayden IR
(651) 653-1854

SOURCE MedClean Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedClean Technologies Partners With Triumvirate Environmental
2. MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer
3. MedClean Technologies Announces 2010 Results
4. MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables
5. MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems
6. MedClean Technologies Announces Second Quarter Results
7. HeartSine® Technologies Launches New Global Website
8. Dynex Technologies to Showcase Agility™ ELISA Processor at MEDICA 2011 - Hall 3, Stand D45-6
9. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
10. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
11. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference
Post Your Comments:
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Arkansas that offers insurance and financial preparation services, is providing an update on ... Rescue organization. , Rock City Rescue is a locally recognized nonprofit that provides ...
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) ... and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton ... until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
Breaking Medicine News(10 mins):